Alfonso Gulias-Herrero

Alfonso Gulias-Herrero

Auto-generated profile, based on publicly available information

Alfonso Gulias-Herrero

Department of Internal Medicine, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Primary Care Diabetes
Verified
Journal Article
Closed access
FMFroylan D. Martínez-Sánchez
Froylan D. Martínez-Sánchez
VVValerie Paola Vargas-Abonce
Valerie Paola Vargas-Abonce
AGAnna Paula Guerrero-Castillo
Anna Paula Guerrero-Castillo
MSManuel De Los Santos-Villavicencio
Manuel De Los Santos-Villavicencio
JEJocelyn Eseiza-Acevedo
Jocelyn Eseiza-Acevedo
MGMiguel Ángel Gómez-Sámano
Miguel Ángel Gómez-Sámano

21 November 2022 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
MGMiguel Ángel Gómez-Sámano
Miguel Ángel Gómez-Sámano
AGAnna Paula Guerrero-Castillo
Anna Paula Guerrero-Castillo
JAJorge Antonio Abarca-Arroyo
Jorge Antonio Abarca-Arroyo
EAElena Cristina Albuja-González
Elena Cristina Albuja-González
HGHans Alessandro García-Bonilla
Hans Alessandro García-Bonilla
AGAlfonso Gulias-Herrero
Alfonso Gulias-Herrero
Background: Abdominal obesity has been associated with an increased risk of insulin resistance, metabolic syndrome, and diabetes. Central fat removal procedures such as liposuction, lipectomy, and abdominoplasty are among the most common surgical procedures. The impact of the latter on the former is controversial and understudied. The authors aimed to explore the effect of subcutaneous fat elimination procedures on insulin resistance measures and adipokine levels. Methods: Relevant studies regarding the effects of surgical subcutaneous fat removal on glucose, insulin, adipokines, and lipid metabolism, as well as blood pressure, were identified by searching PubMed and Ovid–Cochrane without limits in date, type of publication, or language. After the selection process, 24 studies were obtained. The results of the articles were summarized using descriptive statistics. For the final analysis, a randomized effects model was used to evaluate heterogeneity; averages and meta-analytic differences were expressed with a confidence interval of 95%. Results: All studies reported a reduction in weight (−2.64 kg; 95% CI, −4.32 to −0.96; P = 0.002; I2 = 36%; P of I2 < 0.001) and body mass index after liposuction. A significant improvement in triglycerides (−10.06 mg/dL; 95% CI, −14.03 to −6.09; P < 0.001; I2 = 48%; P of I2 = 0.05), serum glucose concentration (−4.25 mg/dL; 95% CI, −5.93 to −2.56; P < 0.001; I2 = 68%; P of I2 < 0.001), serum insulin concentration (−2.86 μIU/mL; 95% CI, −3.75 to −1.97; P < 0.001; I2 = 59%; P of I2 = 0.003), and serum leptin concentration (−7.70 ng/mL; 95% CI, −11.49 to −3.92; P = 0.0001; I2 = 96%; P of I2 < 0.001) was consistently observed. Conclusion: In addition to weight loss, there is a significant decrease in leptin, triglyceride, glucose, and insulin serum concentrations after liposuction, a fact that should be considered in future discussions.

22 February 2022 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Verified
Journal Article
Closed access
PDF file
AMAnaclara Michel-Chávez
Anaclara Michel-Chávez
ECErwin Chiquete
Erwin Chiquete
AGAlfonso Gulías-Herrero
Alfonso Gulías-Herrero
DCDiego Luis Carrillo-Pérez
Diego Luis Carrillo-Pérez
AOAntonio Olivas-Martínez
Antonio Olivas-Martínez
BEBruno Estañol
Bruno Estañol
Background: The early clinical predictors of respiratory failure in Latin Americans with Guillain–Barré syndrome (GBS) have scarcely been studied. This is of particular importance since Latin America has a high frequency of axonal GBS variants that may imply a worse prognosis.Methods: We studied 86 Mexican patients with GBS admitted to theInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, a referral center of Mexico City, to describe predictors of invasive mechanical ventilation (IMV).Results: The median age was 40 years (interquartile range: 26–53.5), with 60.5% men (male-to-female ratio: 1.53). Most patients (65%) had an infectious antecedent (40.6% gastrointestinal). At admission, 38% of patients had a Medical Research Council (MRC) sum score <30. Axonal subtypes predominated (60.5%), with acute motor axonal neuropathy being the most prevalent (34.9%), followed by acute inflammatory demyelinating polyneuropathy (32.6%), acute motor sensory axonal neuropathy (AMSAN) (25.6%), and Fisher syndrome (7%). Notably, 15.1% had onset in upper limbs, 75.6% dysautonomia, and 73.3% pain. In all, 86% received either IVIg (9.3%) or plasma exchange (74.4%). IMV was required in 39.5% patients (72.7% in AMSAN). A multivariate model without including published prognostic scores yielded the time since onset to admission <15 days, axonal variants, MRC sum score 4, and dysautonomia as predictors.Conclusion: These results suggest that EGRIS is a good prognosticator of IMV in GBS patients with a predominance of axonal electrophysiological subtypes, but other early clinical data should also be considered.

1 November 2020 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
CBChristianne Bourlon
Christianne Bourlon
SRSantiago Riviello-Goya
Santiago Riviello-Goya
AAAldo A Acosta-Medina
Aldo A Acosta-Medina
RCRosa E. Caballero-Landinez
Rosa E. Caballero-Landinez
AMAngelica Manrique-Rubio
Angelica Manrique-Rubio
MBMaria T. Bourlon
Maria T. Bourlon
Long-term therapy-related reproductive health side effects impact quality of life of hematopoietic stem cell transplant (HSCT) survivors. Our aim was to evaluate prevalence of gonadal dysfunction (GD) pre- and post- HSCT, analyze factors associated with GD, and rates of fertility assessment (FA) and preservation (FP) in a resource-limited setting. FA and outcomes of patients ≤45 years-old, undergoing HSCT from June 2000 to May 2018 were retrospectively collected. We included 213 patients with a median age of 26 years. Pre-HSCT FA was performed in 71.8%, with a GD rate of 17%. GD was not different between sexes (females 19.5% vs. males 16.1%; p=0.616) and was only associated to increasing age. Rate of cryopreservation in the cohort was 3.3%. A 47.7% of post-HSCT patients completed FA and evidenced an increase in GD rate to 48.9%. Comparing pre-HSCT vs. post-HSCT GD rates, women had a significant increase (19.5% vs. 81.4%; p<0.001) which was not observed in men (16.1% vs. 20.4%; p=0.76). Results were confirmed with multiple imputation analysis accounting for missing data. Female sex, pre-HSCT cytotoxic therapy, myeloablative conditioning, and germ cell tumor (GCT) diagnosis were associated with post-HSCT GD. Reproductive health preservation can be positively impacted when FA and FP are prioritized at initial diagnosis in HSCT candidates, particularly in women with increasing age and men with GCT diagnosis. The low FP success observed, urges implementation of strategies that favor accessibility and improve quality of life of HSCT survivors in low- and middle-income countries.

24 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RMRoopa Mehta
Roopa Mehta
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
LMLeonardo Mancillas-Adame
Leonardo Mancillas-Adame
Marcela Rodríguez-FloresMarcela Rodríguez-Flores
Marcela Rodríguez-Flores
NPNatalia Ramírez Pedraza
Natalia Ramírez Pedraza
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
BACKGROUND Obesity, in particular, visceral adipose tissue has been linked to adverse COVID-19 outcomes. The amount of epicardial adipose tissue (EAT) may have relevant implications given its proximity to the heart and lungs. Here, we explored the role of EAT in increasing the risk for COVID-19 adverse outcomes. METHODS We included 748 patients with COVID-19 attending a reference centre in Mexico City. EAT thickness, sub-thoracic and pericardial fat were measured using thoracic CT scans. We explored the association of each thoracic adipose tissue compartment with critical COVID-19 and mortality according to the presence or absence of obesity. Mediation analyses evaluated the role of EAT in facilitating the effect of age, body mass index and cardiac troponin levels with adverse COVID-19 outcomes. RESULTS EAT thickness was associated with increased risk of COVID-19 mortality (HR 1.18, 95%CI 1.01-1.39) independent of age, gender, comorbid conditions and BMI. Increased EAT was associated with lower SpO2 and PaFi index and higher levels of cardiac troponins, D-dimer, C-reactive protein, and 4C severity score, independent of obesity. EAT mediated 13.1% (95%CI 3.67-28.0%) and 5.1% (95%CI 0.19-14.0%) of the effect of age and 19.4% (95%CI 4.67-63.0%) and 12.8% (95%CI 0.03-46.0%) of the effect of BMI on requirement for intubation and mortality, respectively. EAT also mediated the effect of increased cardiac troponins on myocardial infarction during COVID-19. CONCLUSION EAT is an independent risk factor for severe COVID-19 and mortality independent of obesity. EAT partly mediates the effect of age and BMI and increased cardiac troponins on adverse COVID-19 outcomes.

9 November 2026 in Diabetes Therapy
Verified
Journal Article
Open access
PDF file
AGAlhely Gaytan-Santillan
Alhely Gaytan-Santillan
ASAdrian Soto-Mota
Adrian Soto-Mota
DCDaniel Cuevas-Ramos
Daniel Cuevas-Ramos
RMRoopa Mehta
Roopa Mehta
AGAlfonso Gulias-Herrero
Alfonso Gulias-Herrero
Introduction Continuous glucose monitoring (CGM) is a cornerstone of ambulatory diabetes management, and its utility in the inpatient setting remains underexplored. This study evaluated a CGM-guided management strategy against point-of-care capillary blood glucose (CBG) monitoring in adults who were hospitalized with hyperglycemia. Methods We conducted a prospective, nonrandomized comparative cohort study, reported according to the Strengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement, at a national referral center in Mexico City. A total of 338 adult inpatients with hyperglycemia were allocated to either the CGM group (n = 169) or the standard CBG monitoring group(n = 169). The primary outcome was the percentage of glucose readings between 70 and 180 mg/dL, measured with intermittently scanned CGM in the CGM group and with a four-point daily capillary schedule at 06:00, 12:00, 18:00, and 24:00 in the CBG group. Results The capillary schedule yielded 6123 of 7024 scheduled measurements (87.2% capture), including 1431 at 24:00. Readings in range averaged 54.9% by CGM and 57.8% by CBG, based on approximately 96 and 4 daily measurements per patient, respectively. CBG at 24:00 was 27.0 mg/dL lower than the same patient daytime mean (95% CI, 20.9–33.0 lower; p < 0.001), with 79.2% of midnight readings in range versus 52.4% during the day. Hypoglycemia was distributed across the whole day, with 19.9% of CBG readings below 70 mg/dL recorded at 24:00, and seven patients had hypoglycemia detected only overnight. Time below 70 mg/dL was 10.5% by CGM and 5.6% by CBG; whereas, below 54 mg/dL was 3.7% and 1.4%, respectively. Mean glucose and the coefficient of variation improved from the first to the second half of hospitalization in both groups. Conclusions The two groups recorded a similar percentage of readings in range, however, the sensor detected hypoglycemia twice as often. One in five capillary readings below 70 mg/dL was recorded at 24:00, and a daytime-only schedule would have missed all of them, as well as the hypoglycemia documented overnight in seven patients. Trial registration ClinicalTrials.gov identifier NCT05096858. Enrollment began on 13 April 2020 and the record was first posted on 27 October 2021, hence, the study was in part retrospectively registered.